Market revenue in 2023 | USD 61.2 million |
Market revenue in 2030 | USD 97.7 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | In house |
Fastest growing segment | Contract Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In House, Contract Outsourcing |
Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.
In house was the largest segment with a revenue share of 64.54% in 2023. Horizon Databook has segmented the Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The market in Saudi Arabia is expected to witness lucrative growth due to the increasing incidence of pet diseases and a rise in demand for insurance policies. The market is being driven further by the increasing number of pet owners and favorable initiatives by private players to promote animal healthcare practices.
Furthermore, the growth can be attributed to increased awareness about veterinary diseases and a rise in the prevalence of zoonotic diseases. Furthermore, the high demand for pet care insurance and growing concerns over animal protection are expected to boost the demand for veterinary APIs.
In addition, increased investments in R&D for animal healthcare and favorable government initiatives are expected to drive the veterinary API manufacturing market in Saudi Arabia. According to the study by Pet Secure, Saudi Arabia has the highest proportion of dogs worldwide, with large breeds accounting for 70% of the dog population.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account